AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006
May 4, 2006
30339_dirs_2006-05-04_5b114d3b-dcf2-4dc5-afc7-93ff69d5221a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-05-02
Reporting Person: NEAFSEY JOHN P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-05-02 | Phantom Stock Unit | $ | A | 2000 | Acquired | Common stocks (2000.00) | Direct | |
| 2006-05-02 | Stock Option (Right to Buy) | $36.1000 | A | 6400 | Acquired | 2016-05-02 | Common Stock (6400.00) | Direct |
Footnotes
F1: Awards of phantom stock units are to be settled only in cash upon the reporting person's termination as a director.
F2: Reflects addtional Phantom Stock Units credited through dividend reinvestment based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27